TORONTO, May 15, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is thrilled to formally announce the launch of the Phenesafe AI platform, an AI technology stack specifically designed to derive novel substituted phenethylamine molecules for patent and subsequent development. “Over the past year, our ...

ROUYN-NORANDA, Quebec, May 15, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to inform shareholders that it has acquired by staking a 100% interest in a contiguous claim block of 14 unpatented lode claims situated on the southern flank of the Clover Mountains in Lincoln Co ...

Highlights include: Anomalous radioactivity was detected in 6 out of 10 completed drill holes, assay results are pendingAt Tuning Fork, identification of an extensive hydrothermal system, strong alteration halo, and anomalous radioactivity surrounding drill hole TF-25-16At Richardson, uranium mineralization was extended 50-metres along the Richardson conductor in drill hole RL-25-32 confirming system’s growth potential VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd. ...

Jim Schreiner to return to COO role; Dave Henry to become new leader of Materials Solutions DivisionANDOVER, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”), a global provider of enabling technologies that transform our world, announced today that James A. Schreiner will conclude his tenure as the leader of the Materials Solutions Division (“MSD”) on August 1, 2025, and will transition back to his role as Executive Vice President & Chief Operating Officer of MKS. In this ...

AI Company’s Gross Profit Turns Positive as Company Lands Largest Deal in Its History and Expands Across Luxury and Affordable Multifamily MarketsPALO ALTO, CA, May 15, 2025 (GLOBE NEWSWIRE) -- Cloudastructure, Inc. (Nasdaq: CSAI) (“we,” “us,” “our,” “Cloudastructure” or the “Company”), a cloud-based video surveillance platform with artificial intelligence (“AI”) and computer vision analytics, today reported that for the quarter ending March 31, 2025, revenue soared 212% year-over-year, marking a powerful s ...

Dubai, May 15, 2025 (GLOBE NEWSWIRE) -- Vantage Drilling International Ltd. ("Vantage" or the “Company”) reported a net loss attributable to shareholders of approximately $18.9 million or $1.42 per diluted share for the three months ended March 31, 2025, based on the weighted average shares outstanding, as compared to a net loss attributable to shareholders of approximately $2.9 million or $0.22 per diluted share for the three months ended March 31, 2024. As of March 31, 2025, Vantage had approximately $76 ...

ANDOVER, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”), a global provider of enabling technologies that transform our world, announced today that its shareholders have approved the change of the Company’s name to “MKS Inc.” and the change is effective May 16, 2025. John T.C. Lee, President and CEO of MKS, said: “Since its founding in 1961 as an industrial instruments company, MKS has significantly expanded and entered new markets through organic growth from investment ...

NATALEE subanalysis evaluates Kisqali in pre-menopausal early breast cancer patients, amid rising diagnosis rates in younger patients Pluvicto analysis and Scemblix ASC4START primary endpoint results provide insights into use in earlier settingsFabhalta APPULSE-PNH full results build on Phase III program, reporting new data from expanded PNH population in adults switching from anti-C5Ianalumab Phase II data in immune thrombocytopenia and longer-term pelabresib Phase III data in myelofibrosis show breadth of ...

Press ReleaseNokia and Celesta Capital launch Astranu to advance healthcare imaging technology Startup spin-out from Nokia Bell Labs will commercialize advanced healthcare imaging technology.Venture is the first in a Nokia – Celesta collaboration aiming to create a pipeline of spin outs from Nokia Bell Labs technologies.Astranu’s transformative technology delivers a highly performant, cost-effective imaging system for rapid and accurate 3D imaging of middle-ear conditions and hearing response. 15 May 2025Mu ...

PLAINVIEW, N.Y., May 15, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional sales services, and proprietary medical products, today announced its operating results for the three months ended March 31, 2025. “The Company recorded record first quarter revenue, with revenue of $19.5 million, an increase of 3.9% when compared to the same quarter of the prior year,” commented Dr. Jun ...